Hikal, Pharmaceutical Product Development (PPD) and PRA International - People on the move
Hikal, Pharmaceutical Product Development (PPD) and PRA International have all had people on the move in the world of pharmaceutical outsourcing.
Hikal, Pharmaceutical Product Development (PPD) and PRA International have all had people on the move in the world of pharmaceutical outsourcing.
Caliper Life Sciences has launched a new high throughput (HT) microfluidic assay that automates RNA quality and concentration assessment for gene expression analysis.
The FDA (US Food and Drug Administration) and Gene Logic are to collaborate in developing a set of industry standards for genomic data sent to the regulator.
Swedish speciality pharma company Meda AB has announced its new low dose of Soma (carisoprodol) has been approved by the US Food and Drugs Administration (FDA).
Bioreliance has signed a deal with Gentronix to provide the UK firm's novel DNA damage testing tool as a service for biopharma companies for the first time.
Novartis and Bayer Schering Pharma have finally settled their disputes over multiple sclerosis (MS) drug Betaseron (interferon beta-1b), with an agreement outlined in March now complete.
Pharmacopeia plans to expand the Phase I clinical study of its cardiovascular drug while beginning the next stage of trials, following promising results so far.